Cholecystitis; Gallstone

3

Review clinical trials related to Cholecystitis; Gallstone. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Ultrasound for Postop Lung Issues in Low-Flow Anesthesia

Detecting possible atelectasis and other respiratory problems that may develop immediately after extubation via lung ultrasonography can reduce pulmonary complications by performing necessary interventions such as oxygen support, respiratory exercises, mobilization, and non-invasive mechanical ventilation applications at an early stage. In addition, although low-flow anesthesia is frequently used in daily anesthesia practice, publications showing the effects of its use in laparoscopic cholecystectomy operations on pulmonary complications are limited. On this occasion, this study can be presented as a contribution to the literature.

Participants needed: 110
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Ankara Ataturk Sanatorium Training and Research HospitalUpdated: Jun 5, 2026Locations: 1
Eligibility criteria

Patients with informed consent [+3]

Patients with emergency surgery planned [+5]

Status: Recruiting

EOIB for Laparoscopic Cholecystectomy

Laparoscopic cholecystectomy, while less painful compared to conventional methods, is still a surgery that can cause significant pain for patients. Preventing postoperative pain is crucial for reducing respiratory complications, shortening hospital stays, and increasing patient satisfaction. Interfascial plane blocks have been widely used for postoperative analgesia in recent years worldwide. The External Oblique Intercostal Plane Block is one of the interfascial plane blocks used in abdominal surgeries. In our study, we aimed to compare the postoperative pain scores of patients who underwent laparoscopic cholecystectomy under general anesthesia, specifically between those who received the external oblique intercostal plane block and those who had trocar entry site infiltration.

Participants needed: 60
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research HospitalUpdated: Nov 1, 2024Locations: 1
Eligibility criteria

Patients aged 18 to 65 who will be scheduled for an elective laparoscopic cholec... [+1]

presence of coagulation disorder [+12]

Status: Recruiting

Dutch Cholecystitis Snapshot Study

Background: Cholecystitis is treated by in various types of hospitals by different specialists, and treatment strategy is influenced by logistical and medical reasons and personal preference. This may significantly impact hospital stay and other outcomes. Purpose: To determine the variation in treatment of cholecystitis in the Netherlands and its impact on outcome. Methods: Nation-wide cohort study of all patients diagnosed and treated for cholecystitis during a 6 month period. The primary outcome will be the proportion of patients with an acute cholecystitis in which the guideline is followed. This group will be compared to those in which the guideline is not followed, focussing on total hospital stay and complications. Secondary aims are to determine: factors related to guideline compliance; the best method of cystic duct closure; the best treatment strategy for a \>7-day existing cholecystitis; factors predictive for concomitant common bile duct stones; strategies following gallbladder drainage. Multivariable analysis and propensity score matching will be used when appropriate for the etiological study aims. The TRIPOD guideline for prediction modelling will be used for the predictive study aims. Hospitals will receive their own results, set out against the national average and best practices, thereafter subsequent changes in hospital practice will be recorded. Conclusion: This study will determine the variation in treatment of cholecystitis in the Netherlands and its impact on clinical outcome. Its results will serve as an important incentive to create optimal, uniform cholecystitis treatment in the Netherlands.

Participants needed: 3,000
Trial details
Age: 18-120Biological sex: AllType: ObservationalSponsor: St. Antonius HospitalUpdated: Aug 12, 2024Locations: 1
Eligibility criteria

Not listed